Showing results (1251-1260 of 1,287) with videos related to

Sort By:
Pageof 129
Skeletal Muscle|May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
The Journal of Biological Chemistry|April 2, 2010
Discovery of the selective androgen receptor modulator MK-0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiologyAzriel Schmidt, Donald B Kimmel, Chang Bai, et al.
Regulatory Toxicology and Pharmacology : RTP|June 6, 2022
Current ecotoxicity testing needs among selected U.S. federal agenciesPatricia Ceger, Natalia Garcia-Reyero Vinas, David Allen, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric ModulatorMichael T Rudd, Peter J Manley, Barbara Hanney, et al.
Environmental Health Perspectives|January 9, 2010
Integrating omic technologies into aquatic ecological risk assessment and environmental monitoring: hurdles, achievements, and future outlookGraham Van Aggelen, Gerald T Ankley, William S Baldwin, et al.
JMIR Medical Education|February 10, 2022
A Comprehensive COVID-19 Daily News and Medical Literature Briefing to Inform Health Care and Policy in New Mexico: Implementation StudyLynnMarie Jarratt, Jenny Situ, Rachel D King, et al.
Science Signaling|November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
Environmental Health Perspectives|April 20, 2016
The Next Generation of Risk Assessment Multi-Year Study-Highlights of Findings, Applications to Risk Assessment, and Future DirectionsIla Cote, Melvin E Andersen, Gerald T Ankley, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 129